BioAtla Inc. Common Stock (BCAB)

About BCAB

BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedot…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

41

Website

www.bioatla.com/

Fundamentals

1-day range

$3.04$3.33

Market cap

$5.53M

P/E (trailing)

—

P/E (forward)

-2.42

EPS (trailing)

$-41.82

Dividend yield

—

Beta

0.67

Avg. volume

57.9K

BioAtla Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• BCAB

  BioAtla Inc. Common Stock

  $1.79

  ▼ 42.99%
  Market cap $5.53MP/E —
  $2.81$71.5
• VIVS

  VivoSim Labs Inc. Common Stock

  $0.29

  ▲ 0.00%
  Market cap $5.53MP/E —
  $0.2625$5.3
• AIM

  AIM ImmunoTech Inc. Common Stock

  $0.2558

  ▲ 2.32%
  Market cap $7.51MP/E —
  $0.1901$2.89
• CRIS

  Curis Inc. Common Stock

  $1.49

  ▲ 2.76%
  Market cap $8.59MP/E —
  $1.4$39
• SCNI

  Scinai Immunotherapeutics Ltd. American Depositary Shares

  $2.53

  ▼ 5.60%
  Market cap $1.30MP/E 0.16
  $2.15$16.8
• BTTC

  Black Titan Corporation Ordinary Shares

  $0.4334

  ▼ 7.98%
  Market cap $1.02MP/E —
  $0.4622$39
• BCDA

  BioCardia Inc. Common Stock

  $1.16

  ▼ 0.85%
  Market cap $10.80MP/E —
  $0.75$2.29

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Friday's After-Market Session
  Benzinga · 8/21/2026
• 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
  Benzinga · 8/11/2026

• Christian Vasquez · May 31, 2026 · Tax Withholding

  82 @ $3.93
• Eric Sievers · May 31, 2026 · Tax Withholding

  134 @ $3.93
• Jay M. Short, PhD · May 31, 2026 · Tax Withholding

  259 @ $3.93
• Jay M. Short, PhD · March 12, 2026 · Tax Withholding

  639 @ $0.168
• Christian Vasquez · March 11, 2026 · Tax Withholding

  175 @ $0.169
• Eric Sievers · March 11, 2026 · Tax Withholding

  360 @ $0.169
• Jay M. Short, PhD · March 11, 2026 · Grant

  430.0K
• Eric Sievers · March 10, 2026 · Grant

  240.0K
• Christian Vasquez · March 10, 2026 · Grant

  240.0K

Institutional Ownership

March 31, 2026

Total shares held

288.8K

Total value held

$46.2K

Institutional holders

2